Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06203119
Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe
Sponsor: Peking University Cancer Hospital & Institute
View on ClinicalTrials.gov
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the clinical predictive value of 68Ga-DOTA-BPP in subjects with triple-negative breast cancer. The visual and semiquantitative methods will be used to assess the PET/CT images
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2022-10-01
Completion Date
2024-10
Last Updated
2024-08-19
Healthy Volunteers
No
Conditions
Locations (1)
Ethics Committee of Peking University Cancer Hospital
Beijing, Beijing Municipality, China